Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

China National Medical Products Administration Approves Sinovant's Clinical Trial Application for Derazantinib

prnewswireApril 29, 2019

Tag: china , CTA , NMPA

PharmaSources Customer Service